[Tc-99m-DMSA (V)] in Detection of Metastases of Medullary Thyroid Carcinoma

被引:0
作者
Dabiri, Shahram [1 ]
机构
[1] Tabriz Univ Med Sci, Dept Nucl Med, Tabriz, Iran
来源
IRANIAN JOURNAL OF NUCLEAR MEDICINE | 2006年 / 14卷 / 02期
关键词
Medullary thyroid carcinoma; Tc-99m-DMSA (V); Metastasis;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: Medullary thyroid carcinoma (MTC) is a rare thyroid cancer secreting calcitonin (CT) which is the most sensitive and specific tumor marker for MTC. This type of thyroid cancer is able to metastasize to different body areas including regional lymph nodes, lungs, liver and bone. The aim of this study was to assess the sensitivity and specificity of [Tc-99m-DMSA (V)] whole body scan (WBS) in detection of metastases in MTC. Methods: This descriptive and prospective study was performed in 15 patients with MTC referred to our nuclear medicine centre since 2004 to 2005. These patients were compared regarding age, sex, and duration of the disease. Sensitivity and specificity of each diagnostic modality in detection of metastases were calculated and compared statistically. Results: [Tc-99m-DMSA (V)] showed 91% sensitivity and 75% specificity as compared with serum calcitonin as gold standard. The figures for CT scan were 82% and 45%, respectively. CEA showed 64% sensitivity and 50% specificity. Conclusion: It is concluded that despite the slightly lower sensitivity and specificity of [99mTc-DMSA (V)] as compared to calcitonin (Gold-standard method), this radiotracer can be used for identification of recurrence or metastasis of medullary thyroid carcinoma.
引用
收藏
页数:10
相关论文
共 37 条
[1]   Disappointing results with Tc-99m tetrofosmin for detecting medullary thyroid carcinoma metastases comparison with Tc-99m VDMSA and TI-201 [J].
Adalet, I ;
Demirkale, P ;
Ünal, S ;
Ouz, H ;
Alagöl, F ;
Cantez, S .
CLINICAL NUCLEAR MEDICINE, 1999, 24 (09) :678-683
[2]   Determination of medullary thyroid carcinoma metastases by 201Tl, 99Tcm(V)DMSA, 99Tcm-MIBI and 99Tcm-tetrofosmin [J].
Adalet, I ;
Koçak, M ;
Oguz, H ;
Alagöl, F ;
Cantez, S .
NUCLEAR MEDICINE COMMUNICATIONS, 1999, 20 (04) :353-359
[3]  
Adams S, 2001, CANCER-AM CANCER SOC, V92, P263, DOI 10.1002/1097-0142(20010715)92:2<263::AID-CNCR1318>3.0.CO
[4]  
2-Z
[5]   Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings [J].
Adams, S ;
Baum, RP ;
Hertel, A ;
Schumm-Draeger, PM ;
Usadel, KH ;
Hör, G .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (09) :1277-1283
[6]  
Ambrus E, 1997, ANTICANCER RES, V17, P1599
[7]   Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery [J].
Arslan, N ;
Ilgan, S ;
Yuksel, D ;
Serdengecti, M ;
Bulakbasi, N ;
Ugur, O ;
Ozguven, MA .
CLINICAL NUCLEAR MEDICINE, 2001, 26 (08) :683-688
[8]   IN-111-OCTREOTIDE AND TC-99M(V)-DIMERCAPTOSUCCINIC ACID STUDIES IN THE IMAGING OF RECURRENT MEDULLARY-THYROID CARCINOMA [J].
BERNA, L ;
CABEZAS, R ;
MORA, J ;
TORRES, G ;
ESTORCH, M ;
CARRIO, I .
JOURNAL OF ENDOCRINOLOGY, 1995, 144 (02) :339-345
[9]   Preoperative diagnosis of medullary thyroid carcinoma: Fine needle aspiration cytology as compared with serum calcitonin measurement [J].
Bugalho, MJM ;
Santos, JR ;
Sobrinho, L .
JOURNAL OF SURGICAL ONCOLOGY, 2005, 91 (01) :56-60
[10]  
Celentano L, 1995, Q J Nucl Med, V39, P131